We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

3 hedge funds and large institutions have $16.6M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $17.6M → $16.6M (-$1.04M)

18% less call options, than puts

Call options by funds: $164K | Put options by funds: $199K

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
–
Reduced
–
Closed
–
Calls
$164K
Puts
$199K
Net Calls
-$35K
Net Calls Change
-$68K

Top Buyers

Rank Fund Capital Flow
1
HVC
Healthcare Value Capital
New Jersey
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
RCM
Rotella Capital Management
Washington
-$79K
2
HighTower Advisors
HighTower Advisors
Illinois
-$73K
3
Millennium Management
Millennium Management
New York
-$54K
4
EEG
E.E. Geduld
-$47K
5
Creative Planning
Creative Planning
Kansas
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$11.2M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.24M – – –
HVC
3
Healthcare Value Capital
New Jersey
$1.11M +$1.91M +1 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$449K – – –
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$441K – – –
BFA
6
BlackRock Fund Advisors
California
$226K – – –
Franklin Resources
7
Franklin Resources
California
$186K – – –
Northern Trust
8
Northern Trust
Illinois
$128K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$123K – – –
CC
10
Callan Capital
California
$95K – – –
BIP
11
Brandes Investment Partners
California
$91K – – –
SM
12
Sabby Management
Florida
$64K – – –
Goldman Sachs
13
Goldman Sachs
New York
$59K – – –
Bank of America
14
Bank of America
North Carolina
$45K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$32K – – –
BA
16
BlackRock Advisors
Delaware
$28K – – –
State Street
17
State Street
Massachusetts
$18K – – –
FANJ
18
Financial Architects (New Jersey)
New Jersey
$17K – – –
Morgan Stanley
19
Morgan Stanley
New York
$17K – – –
Wells Fargo
20
Wells Fargo
California
$17K – – –
BIT
21
BlackRock Institutional Trust
California
$15K – – –
BIM
22
BlackRock Investment Management
Delaware
$14K – – –
Group One Trading
23
Group One Trading
Illinois
$13K – – –
AIG
24
American International Group
New York
$10.9K – – –
Citigroup
25
Citigroup
New York
$2K – – –
1
2

SEEL Hedge Fund Activity: Q2 2015 in Review

3 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q2 2015, worth a combined $16.6M — down 5.9% from $17.6M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SEEL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Healthcare Value Capital, opening a new position worth an estimated $1.91M. The largest seller was Rotella Capital Management, cutting an estimated $79K.

  • 3 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q2 2015, up from 2 in Q1 2015.
  • Funds reported $16.6M of Seelos Therapeutics, Inc. Common Stock stock for Q2 2015, down 5.9% quarter-over-quarter.
  • 1 fund opened new Seelos Therapeutics, Inc. Common Stock positions in Q2 2015 and 0 closed out, a net change of +1 holder.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q2 2015 was Healthcare Value Capital, an estimated $1.91M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q2 2015 was Rotella Capital Management, an estimated $79K sold.

Based on aggregated 13F filings for Q2 2015.